105 related articles for article (PubMed ID: 3155521)
1. Regulation of thymidylate synthase enzyme synthesis in 5-fluorodeoxyuridine-resistant mouse fibroblasts during the transition from the resting to growing state.
Jenh CH; Rao LG; Johnson LF
J Cell Physiol; 1985 Jan; 122(1):149-54. PubMed ID: 3155521
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo analysis of the control of dihydrofolate reductase gene transcription in serum-stimulated mouse fibroblasts.
Santiago C; Collins M; Johnson LF
J Cell Physiol; 1984 Jan; 118(1):79-86. PubMed ID: 6690454
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase gene amplification in fluorodeoxyuridine-resistant mouse cell lines.
Jenh CH; Geyer PK; Baskin F; Johnson LF
Mol Pharmacol; 1985 Jul; 28(1):80-5. PubMed ID: 2991733
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the multiple 5' and 3' termini of poly(A)+ and poly(A)-deficient thymidylate synthase mRNA in growth-stimulated mouse fibroblasts.
DeWille JW; Harendza CJ; Jenh CH; Johnson LF
J Cell Physiol; 1989 Feb; 138(2):358-66. PubMed ID: 2918037
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
Berger SH; Jenh CH; Johnson LF; Berger FG
Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthetase overproduction in 5-fluorodeoxyuridine-resistant mouse fibroblasts.
Rossana C; Gollakota Rao L; Johnson LF
Mol Cell Biol; 1982 Sep; 2(9):1118-25. PubMed ID: 6217415
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dihydrofolate reductase gene transcription in methotrexate-resistant mouse fibroblasts.
Wu JS; Johnson LF
J Cell Physiol; 1982 Feb; 110(2):183-9. PubMed ID: 6279683
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
9. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
Davis ST; Berger SH
Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
[TBL] [Abstract][Full Text] [Related]
10. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
Chu E; Koeller DM; Johnston PG; Zinn S; Allegra CJ
Mol Pharmacol; 1993 Apr; 43(4):527-33. PubMed ID: 8474431
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts.
Navalgund LG; Rossana C; Muench AJ; Johnson LF
J Biol Chem; 1980 Aug; 255(15):7386-90. PubMed ID: 7391086
[TBL] [Abstract][Full Text] [Related]
12. Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma.
Baskin F; Carlin SC; Kraus P; Friedkin M; Rosenberg RN
Mol Pharmacol; 1975 Jan; 11(1):105-17. PubMed ID: 123312
[No Abstract] [Full Text] [Related]
13. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
15. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene.
Yang Z; Cloud A; Hughes D; Johnson LF
Cancer Gene Ther; 2006 Jan; 13(1):107-14. PubMed ID: 16052228
[TBL] [Abstract][Full Text] [Related]
16. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional regulation of thymidylate synthase gene expression.
Johnson LF
J Cell Biochem; 1994 Apr; 54(4):387-92. PubMed ID: 8014187
[TBL] [Abstract][Full Text] [Related]
18. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
Lee TX; Johnson LF
J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.
Welsh SJ; Titley J; Brunton L; Valenti M; Monaghan P; Jackman AL; Aherne GW
Clin Cancer Res; 2000 Jun; 6(6):2538-46. PubMed ID: 10873110
[TBL] [Abstract][Full Text] [Related]
20. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance.
Fantz CR; Shaw D; Moore JG; Spencer HT
Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
